These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6721985)

  • 41. Dose-dependent prednisolone kinetics.
    Tanner A; Bochner F; Caffin J; Halliday J; Powell L
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):571-8. PubMed ID: 436359
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of subtle changes in glucocorticoid negative feedback using prednisolone: comparison of salivary free cortisol and urinary cortisol metabolites as endpoints.
    Jerjes WK; Cleare AJ; Wood PJ; Taylor NF
    Clin Chim Acta; 2006 Feb; 364(1-2):279-86. PubMed ID: 16168400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prednisolone elimination in human saliva.
    Al-Habet SM; Rogers HJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):485-7. PubMed ID: 4055160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
    Wagner JG; Wexler D; Ağabeyoğlu IT; Bergstrom RF; Sakmar E; Kay DR
    J Lab Clin Med; 1981 Apr; 97(4):487-501. PubMed ID: 7205057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma prednisolone levels during intravenous therapy in acute colitis.
    Berghouse LM; Elliott PR; Lennard-Jones JE; English J; Marks V
    Gut; 1982 Nov; 23(11):980-83. PubMed ID: 7129207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age- and dose-dependent naproxen disposition in Fischer 344 rats.
    Satterwhite JH; Boudinot FD
    J Gerontol; 1991 Nov; 46(6):B222-7. PubMed ID: 1940073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal variation in the disposition of theophylline and its metabolites.
    St-Pierre MV; Spino M; Isles AF; Tesoro A; MacLeod SM
    Clin Pharmacol Ther; 1985 Jul; 38(1):89-95. PubMed ID: 4039998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma protein binding of prednisolone in normal volunteers and arthritic patients.
    Ağabeyoğlu IT; Bergstrom RF; Gillespie WR; Wagner JG; Kay DR
    Eur J Clin Pharmacol; 1979; 16(6):399-404. PubMed ID: 527636
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of uremia on pharmacokinetics and protein binding of prednisolone.
    Bergrem H
    Acta Med Scand; 1983; 213(5):333-7. PubMed ID: 6880855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
    Nichols AI; D'Ambrosio R; Pyszczynski NA; Jusko WJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):963-70. PubMed ID: 2778721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acebutolol disposition after intravenous administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):557-67. PubMed ID: 913023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of advanced age on the disposition of acetazolamide.
    Chapron DJ; Sweeney KR; Feig PU; Kramer PA
    Br J Clin Pharmacol; 1985 Mar; 19(3):363-71. PubMed ID: 3986087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone.
    Hsueh WA; Paz-Guevara A; Bledsoe T
    J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The transplacental passage of prednisone and prednisolone in pregnancy near term.
    Beitins IZ; Bayard F; Ances IG; Kowarski A; Migeon CJ
    J Pediatr; 1972 Nov; 81(5):936-45. PubMed ID: 5086721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.